Mode
Text Size
Log in / Sign up

Post-COVID-19 Condition

Part of SARS-CoV-2 infection

Subtypes of Post-COVID-19 Condition

Cardiopulmonary long COVID 1 Multisystem long COVID 1 Neuropsychiatric long COVID 1 Post-COVID-19 Olfactory Dysfunction 1

13 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials for Post-COVID-19 Condition

8 trials tracked for Post-COVID-19 Condition: 2 in phase 3 or 4.

8Trials tracked
2Phase 3 & 4
0Recruiting
0With published results
Phase distribution
Phase 3 2 Phase 2 4 Other / NA 2
  1. Phase 3 Homeopathic Treatment of Post-acute COVID-19 Syndrome Completed
  2. Phase 3 Сlinical Trial of Efficacy and Safety of Prospekta in the Treatment of Post-COVID-19 Asthenia. Completed
  3. Phase 2 Study to Evaluate the Efficacy and Safety of Ampligen in Patients With Post-COVID Conditions Completed
  4. Phase 2 Vortioxetine for Post-COVID-19 Condition Completed
  5. Phase 2 Randomized Double-Blind Phase 2 Study of Allogeneic HB-adMSCs for the Treatment of Chronic Post-COVID-19 Syndrome Completed
  6. Phase 2 Paxlovid for Treatment of Long Covid Completed
Show 2 more trials
  1. N/A Cognitive Rehabilitation in Post-COVID-19 Syndrome Completed
  2. N/A Transcutaneous Electrical Nerve Stimulation (TENS) in Patients With Postacute Sequelae of Sars-CoV-2 Completed

Showing the 8 most-cited and recently-updated of 8 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.

Research across SARS-CoV-2 infection

Related studies from across the SARS-CoV-2 infection family.

Structural failures in surveillance infrastructure and zoonotic emergence increase global pandemic risks
Neurology Sys. Review
Structural failures in surveillance infrastructure and zoonotic emergence increase global pandemic risks Global health experts identify gaps in pandemic and disease tracking
This narrative review examines the escalating threats from zoonotic emergence, antimicrobial resistance, and climate-sensitive disease expan…
Weak links in how we track animal and environmental diseases could make the next global pandemic harder to stop.
Baricitinib plus remdesivir recovery benefit similar across BMI in COVID-19
Infectious Disease RCT
Baricitinib plus remdesivir recovery benefit similar across BMI in COVID-19 Adding baricitinib to remdesivir for COVID-19 shows consistent results
This secondary analysis of a randomized trial in 942 hospitalized adults with COVID-19 found that baricitinib plus remdesivir improved time …
New data shows that adding the drug baricitinib to remdesivir helps hospitalized COVID-19 patients recover regardless of their body weight.
Pantoprazole Benefits COVID-19 ICU Patients Without Raising Mortality
Emergency Medicine RCT
Pantoprazole Benefits COVID-19 ICU Patients Without Raising Mortality Trial shows pantoprazole helps prevent gastrointestinal bleeding in COVID patients
In critically ill COVID-19 patients, pantoprazole reduced GI bleeding without increasing mortality, though infection itself worsened outcome…
A study of critically ill patients shows that the medication pantoprazole helps prevent serious stomach bleeding in those with COVID-19.
Neutrophil-to-lymphocyte ratio shows 83.9% sensitivity and 83.9% specificity distinguishing dengue from COVID-19
Emergency Medicine Meta-analysis
Neutrophil-to-lymphocyte ratio shows 83.9% sensitivity and 83.9% specificity distinguishing dengue from COVID-19 Neutrophil-to-lymphocyte Ratio Helps Distinguish Dengue From COVID-19
This meta-analysis evaluated the diagnostic accuracy of the neutrophil-to-lymphocyte ratio (NLR) for distinguishing dengue fever from COVID-…
A blood test ratio may help doctors tell the difference between dengue fever and COVID-19 infections in patients showing similar symptoms.
High intensity exercise training improves dyspnoea management across multiple chronic respiratory and neuromuscular conditions
Psychiatry Sys. Review
High intensity exercise training improves dyspnoea management across multiple chronic respiratory and neuromuscular conditions High intensity exercise helps people with chronic breathing difficulties
This narrative review examines the role of exercise training, specifically higher intensities, for managing dyspnoea in patients with COPD, …
People living with conditions like COPD or Long-COVID may find relief from shortness of breath through specific types of high-intensity exer…
Female sex and acute severity increase odds of post-COVID outcomes in hospitalized patients
Primary Care & Family Medicine Meta-analysis
Female sex and acute severity increase odds of post-COVID outcomes in hospitalized patients Specific risk factors increase the likelihood of long-term COVID effects
This meta-analysis of observational data identifies several risk factors associated with adverse post-COVID outcomes in previously hospitali…
Certain factors like being female, having high blood pressure, or needing intensive care can increase the risk of lingering symptoms after C…
Autoantibodies neutralizing type I IFNs found in 7.9% of COVID-19 patients, strongly linked to severity
Infectious Disease Meta-analysis
Autoantibodies neutralizing type I IFNs found in 7.9% of COVID-19 patients, strongly linked to severity Antibodies That Block Immune Signals Linked to Severe COVID-19
This meta-analysis of 11,380 individuals found a 7.9% pooled prevalence of autoantibodies neutralizing type I IFNs (AAN-IFN-I) in SARS-CoV-2…
A review found that certain antibodies that block the body's early immune response are more common in severe COVID-19 cases.
Cytomegalovirus and Long COVID represent convergent failures of host-virus resilience networks and inflammatory circuits
Infectious Disease Sys. Review
Cytomegalovirus and Long COVID represent convergent failures of host-virus resilience networks and inflammatory circuits Cytomegalovirus may play a role in the development of Long COVID
This mini-review explores the intersection of Cytomegalovirus (CMV) biology and Long COVID through a framework of declining organismal resil…
A new theory suggests that a common virus called CMV might drive immune aging and contribute to the symptoms of Long COVID.
Heterologous booster strategies and hybrid immunity broaden immune protection against COVID-19 variants
Primary Care & Family Medicine Sys. Review
Heterologous booster strategies and hybrid immunity broaden immune protection against COVID-19 variants COVID-19 Vaccine Immunity Wanes, But Boosters and Hybrid Immunity Help
This narrative review examines the durability of vaccine-induced immunity, heterologous boosters, and hybrid immunity in Saudi Arabian popul…
COVID-19 vaccine protection fades over time, but boosters and prior infection can broaden immunity. Saudi data show strong protection agains…
Anosmia and taste dysfunction occur in 44% and 46% of COVID-19 patients respectively
Primary Care & Family Medicine Meta-analysis
Anosmia and taste dysfunction occur in 44% and 46% of COVID-19 patients respectively COVID-19 smell and taste loss common in Saudi patients
This meta-analysis of 26,068 patients in Saudi Arabia found a pooled prevalence of anosmia at 44% (95% CI: 37-52%) and taste dysfunction at …
Nearly half of COVID-19 patients in Saudi Arabia lose smell or taste, a new analysis finds.
One Health diagnostics improve pathogen detection and outbreak prediction through cross-sector collaboration and technological innovation
Psychiatry Sys. Review
One Health diagnostics improve pathogen detection and outbreak prediction through cross-sector collaboration and technological innovation One Health approach could stop future pandemics before they start
This structured narrative review examines One Health diagnostic strategies to address zoonotic diseases including SARS, Ebola, and COVID-19.…
A new review shows that combining human, animal, and environmental health monitoring can catch outbreaks like SARS and COVID-19 earlier.
AI models provide high accuracy for pulmonary inflammation and COVID-19 detection in diverse populations
Rheumatology Sys. Review
AI models provide high accuracy for pulmonary inflammation and COVID-19 detection in diverse populations Artificial Intelligence Shows Promise for Detecting Lung Inflammation
This mini-review synthesizes evidence on artificial intelligence applications for detecting pulmonary inflammation and managing perioperativ…
New research shows that artificial intelligence tools can accurately identify lung conditions like pneumonia and COVID-19 from medical imagi…

Questions about Post-COVID-19 Condition

What conditions affect children and adolescents in the US with Post-COVID-19 symptoms?

Children and adolescents with post-COVID-19 condition commonly experience fatigue, lack of concentration, muscle pain, headache, and sleep problems, though symptoms vary and are less frequent than in adults.

Full answer →
How long can COVID-like symptoms last after a positive or negative test?

COVID-like symptoms can last up to 12 months after a positive or negative test, with fatigue and brain fog being common long-term issues.

Full answer →
What are the specific symptoms of Post-COVID-19 Condition in children?

Children with Post-COVID-19 Condition commonly experience fatigue, exertion intolerance, anxiety, and respiratory symptoms like cough or shortness of breath, often after mild acute illness.

Full answer →
Are my long-term symptoms after SARS-CoV-2 infection more common than other viruses?

Some long-term symptoms like fatigue, brain fog, and pulmonary embolism are more common after SARS-CoV-2 than other respiratory viruses, but many symptoms appear similar across post-viral syndromes.

Full answer →
Can a digital cognitive assessment study help track my Post-COVID-19 condition?

Digital cognitive assessments can help track Post-COVID-19 condition by measuring brain function and comparing results to standard tests to see if symptoms like brain fog are linked to the virus.

Full answer →
See all 5 questions about Post-COVID-19 Condition →